CHICAGO — Female pattern hair loss is a common condition for menopausal women, but options to reverse and regrow hair are available if patients are diagnosed and treated, according to a speaker ...

Female pattern hair loss: a pilot study investigating combination therapy with low-dose oral minoxidil and spironolactone. International Journal of Dermatology. https://pubmed.ncbi.nlm.nih.gov ...

Finasteride is FDA-approved for male pattern hair loss but is sometimes prescribed off-label for postmenopausal women with female pattern hair loss. This type of hair loss is primarily due to ...

Female pattern hair loss, for example, affects about 30 million women in the United States and many adults experience telogen effluvium at some point in their lives.

Female pattern hair loss, for example, affects about 30 million women in the United States and many adults experience telogen effluvium at some point in their lives.

Like many things, hair loss isn't one-size-fits all. And that's especially true in terms of where it occurs on the head. Maybe you're dealing with thinning at just the crown or along your part line.

The study, led by Dr. Sukanya Chaikittisilpa, recruited nearly 200 menopausal women ages 50 to 65 to be evaluated for hair thinning, or female-pattern hair loss.

Female pattern hair loss can be incredibly distressing for women and is, unfortunately, quite common. This small cross-sectional study conducted in women seen at a menopause clinic in Thailand ...

Of the participants, 52.2% experienced female pattern hair loss. Of those women, 73.2% had mild hair loss, 22.6% had moderate hair loss, and 4.3% had severe hair loss.

Female pattern hair loss (FPHL) is the leading cause of hair loss in women. Clinically known as androgenic or andro­genetic alopecia, the hairs miniaturize over time. FPHL can happen at any time ...

Just as with male-pattern baldness, there are treatments that can help women’s diffuse hair loss, up to a point. Minoxidil (Rogaine), the only FDA-approved drug for female hair loss, can often ...